Park Ha Biological Technology Co., Ltd. (BYAH) — Capital Reinvestment Ratio
Park Ha Biological Technology Co., Ltd. (BYAH) has a Capital Reinvestment Ratio of 0.09x as of October 2024, meaning it reinvests 0% of its operating cash flow ($960.47K) in capital expenditures ($85.57K). Check BYAH goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Park Ha Biological Technology Co., Ltd. Capital Reinvestment Ratio (2022–2024)
This chart tracks Park Ha Biological Technology Co., Ltd.'s Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see Park Ha Biological Technology Co., Ltd. (BYAH) cash flow conversion.
Annual Capital Reinvestment Ratio for Park Ha Biological Technology Co., Ltd. (2022–2024)
Year-by-year Capital Reinvestment Ratio for Park Ha Biological Technology Co., Ltd. from 2022 to 2024. See Park Ha Biological Technology Co., Ltd. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | $960.47K | $85.57K | ▼ -50.3% |
| 2023 | 0.18x | $126.54K | $22.68K | ▲ +2073.8% |
| 2022 | 0.01x | $1.44 Million | $11.89K | — |